KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Profit After Tax (2016 - 2025)

Historic Profit After Tax for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to -$3.8 million.

  • LifeMD's Profit After Tax rose 2049.71% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.0 million, marking a year-over-year increase of 5480.69%. This contributed to the annual value of -$21.4 million for FY2024, which is 394.75% down from last year.
  • According to the latest figures from Q3 2025, LifeMD's Profit After Tax is -$3.8 million, which was up 2049.71% from -$1.6 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Profit After Tax registered a high of $348067.0 during Q1 2025, and its lowest value of -$18.0 million during Q4 2021.
  • In the last 5 years, LifeMD's Profit After Tax had a median value of -$6.8 million in 2024 and averaged -$8.2 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first crashed by 39397.89% in 2021, then surged by 10514.26% in 2025.
  • LifeMD's Profit After Tax (Quarter) stood at -$18.0 million in 2021, then skyrocketed by 33.72% to -$11.9 million in 2022, then skyrocketed by 68.73% to -$3.7 million in 2023, then plummeted by 32.33% to -$4.9 million in 2024, then rose by 22.93% to -$3.8 million in 2025.
  • Its Profit After Tax stands at -$3.8 million for Q3 2025, versus -$1.6 million for Q2 2025 and $348067.0 for Q1 2025.